Progress in Recombinant DNA Technology to Provide Boost to Market

Over the past couple of decades, investments toward the development of advanced enzyme engineering technologies have witnessed exponential growth due to the widening application of biocatalysts across the medical sector. At present, scientists and researchers are focusing on addressing the shortcoming of conventional medical enzyme technologies, which is projected to redefine the future of the medical enzyme technology market during the forecast period. Several attempts are being made to enhance thermo-stability and other properties of medical-grade enzymes, which are expected to improve the overall prospects of the global medical enzyme technology market during the assessment period.

Strides taken by the recombinant DNA technology has played a key role in opening up new avenues for enzyme engineering due to which, diverse groups of effective enzymes are increasingly being developed. These enzymes are increasingly being used in various medical fields, including structural biology, diagnostics, biochemistry, biocatalysts, and therapeutics, among others. The past few years have witnessed consistent development across the enzyme engineering sector and the trend is expected to gain considerable momentum in the forthcoming decade. At the back of these factors, along with an array of underlying drivers, the global medical enzyme technology market is expected to attain a market value of ~US$ 6.8 Bn by the end of 2030.

medical enzymes technology market infographic

Request a sample to get extensive insights into the Medical Enzyme Technology Market

Growing Importance in Clinical Diagnosis and Treatment to Aid Market Growth

At present, medical enzyme technology is aimed at improving the efficacy of enzymatic diagnosis. The Medical enzyme technology is increasingly being deployed to enhance enzymatic diagnostic techniques across the world– a factor that is expected to provide an impetus for the growth of the global medical enzyme technology market. In addition, the growing adoption of enzymes for disease prevention and treatment is a leading factor that is projected to accelerate innovations across the medical enzyme technology market. Moreover, due to research and development, an array of enzymes are being used to address a host of medical problems. For instance, trypsin is increasingly being used to fasten wound healing dissolving blood clots, etc. to eliminate the necrotic tissue and inhibit the growth of contaminating microorganisms.

Furthermore, the medical enzyme technology is extensively being used in several applications, including disease treatment such as cancer, metabolic disorders, etc. For instance, L-asparaginase is being used for cancer treatment, as it restricts the growth of cancer cells. Multi-enzyme tablets such as protease have also gained considerable popularity as an anti-inflammatory due to which, the demand for the same is likely to witness consistent growth. While advancements in the medical enzyme technology market continue to fuel the development of new diagnostic reagents in medical treatment, enzymes are increasingly being used in medicine production. Over the past few years, studies have revealed that enzymes play a pivotal role in the field of clinical diagnosis and treatment. Advancements in bioengineering coupled with soaring interest in the medical enzyme technology are some of the top factors that are likely to accelerate the growth of the global medical enzyme technology market during the assessment period.

Research and Development Activities Likely to Boost Adoption of New Technologies

At present, medical enzyme technologies are predominantly emphasizing on improving the quality and efficacy of drugs that are used to treat a range of medical conditions, including diabetes, obesity, and cancer. Research and development activities are expected to set the tone for the future of the global medical enzyme technology market in the upcoming years. Over the past few years, researchers are increasingly focusing on enhancing the efficacy of drugs used to address obesity, cancer, and other treatments by deploring the medical enzyme technology.

In addition, a recent discovery of a new enzyme is expected to improve the quality of the drugs used to treat these conditions. In the past few years, an array of drugs that primarily focus on HDAC enzymes have gained considerable attention from drug developers and other stakeholders operating in the global medical enzyme technology market due to their contribution in building resistance toward cancer treatments.

medical enzymes technology market segmentation

To understand how our report can bring difference to your business strategy, Ask for a brochure

Researchers Focus on Exploring Potential Benefits of Human Enzymes to Curb COVID-19

The ongoing COVID-19 pandemic has led to considerable developments across the healthcare sector. While several core industrial sectors are suffering major losses during the pandemic due to the lockdown, the healthcare sector is increasingly being pressurized to discover a potential vaccine, drugs, or medication to curb the novel COVID-19 disease. At present, considerable research is being carried out to explore the potential of human enzymes to exacerbate COVID-19. Drug developers, along with the research fraternity are exploring different strategies for COVID-19 management and treatment by investigating the benefits of human enzymes for the same. While the market growth is expected to remain sluggish in the first half of 2020, the potential or new discoveries that are likely to offer promising results in the fight against COVID-19 could provide a boost to the prospects of medical enzyme technology market.

Expanding operations in future? To get the perfect launch ask for a custom report 

Analysts’ Viewpoint

The global medical enzyme technology market is expected to grow at an impressive CAGR during the assessment period. Advancements in enzyme engineering coupled with rapid development in the DNA technology will play a key role in the overall development of the global enzyme technology market during the assessment period. In addition, research and development activities will play an important role in the discovery of new medical enzyme technologies that are likely to improve the quality and efficacy of drugs used to treat cancer, obesity, and diabetes. Market players should focus on research and collaborate with research & scientific institutes to establish a solid foothold in the medical enzyme technology market landscape during the forecast period.

Medical Enzyme Technology Market: Overview

  • The global medical enzyme technology market was valued at US$ 3.7 Bn in 2019. It is projected to expand at a considerable CAGR from 2020 to 2030. Enzymes can be defined as the complex proteins that catalyze a specific reaction or a chemical change in all parts of the body. The medical applications of enzymes have been in development rampantly owing to their innate availability and their magnitude of rewards offered in disease treatment and as diagnostic tools.
  • Rise in demand for medical enzyme technology can be attributed to the increasing prevalence of chronic diseases, including cancer and cardiovascular diseases, growing usage of enzyme therapies, increasing investment in research and development, strategic partnerships among market players, and rising use of enzymes for various therapeutic and diagnostic purposes, among others

Medical Enzyme Technology Market: Segmentation

  • The global medical enzyme technology market has been segmented based on enzyme type, application, and region
  • In terms of enzyme type, the global medical enzyme technology market has been categorized into digestive enzymes, thrombolytic enzymes, hydrolases, and others. The digestive enzymes segment has been further segmented into L-asparginase, lactase, and others. The thrombolytic enzymes segment has been further divided into streptokinase, urokinase, and others. The hydrolases segment includes hyaluronidase, lysozyme, and others as sub-segments. The medical enzyme technology market was dominated by the hydrolases segment in 2019.
  • Based on application, the global medical enzyme technology market has been classified into disease treatment, diagnostic tools, biomedical research, and others. The disease treatment segment is further divided into cancer (chemotherapy), metabolic disorders, and others. The diagnostic tools segment is further segmented into renal diseases, cancer, and others. The disease treatment segment dominated the medical enzyme technology market in 2019.

Medical Enzyme Technology Market: Regional Segmentation

  • In terms of region, the global medical enzyme technology market has been classified into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
  • North America dominated the global medical enzyme technology market in 2019, and the trend is expected to continue during the forecast period. Expansion of the medical enzyme technology market in the region can be attributed to increasing prevalence of chronic diseases, growing demand for enzyme replacement therapies, increasing investment in research and development, and strong presence of market players, among others.
  • Europe was the second highest revenue-generating region in the medical enzyme technology market in 2019. Growth of the medical enzyme technology market in the region can be attributed to the presence of leading market players, rise in adoption of technological advancements in medical enzyme technology, increase in awareness among the people about enzyme therapies, and strategic acquisitions & partnerships among leading players.
  • The medical enzyme technology market in Asia Pacific is anticipated to expand at a high CAGR from 2020 to 2030. Expansion of the medical enzyme technology market in the region can be attributed to the increasing awareness among people, significant advancements in biotechnology, increase in adoption of technological advancements, and rise in pharmaceutical production.

Medical Enzyme Technology Market: Major Players

  • Key players operating in the global medical enzyme technology market include 
    • Thermo Fisher Scientific Inc.
    • Merck KGaA
    • Genzyme Corporation (Sanofi)
    • Promega Corporation
    • Asahi Kasei Corporation
    • Takeda Pharmaceutical Company Limited
    • Cytiva (Danaher)
    • Agilent Technologies, Inc.
    • Sun Pharmaceutical Industries Ltd.
    • Amano Enzyme Inc.
    • Novozymes A/S
  • The market for medical enzyme technology is dominated by few players. Thermo Fisher Scientific, Inc. is one of the leading players in the medical enzyme technology market. The company is engaged in offering a range of enzymes through its Affymetrix business.
  • Companies in the medical enzyme technology market have been adopting inorganic growth strategies to consolidate their position in the global medical enzyme technology market. For instance, In October 2018, Thermo Fisher Scientific, Inc. acquired Advanced Bioprocessing business. This acquisition is likely to benefit the Life Sciences Solutions segment of the company.

Medical Enzyme Technology Market – Scope of the Report

TMR’s report on the global medical enzyme technology market studies the past as well as current growth trends and opportunities to gain valuable insights of these indicators for the global market during the forecast period from 2020 to 2030. The report provides the overall revenue of the global medical enzyme technology market from 2018 to 2030, considering 2019 as the base year and 2030 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global medical enzyme technology market for the forecast period.

The report has been prepared after an extensive research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with market leaders and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global medical enzyme technology market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts also employed a combination of top-down and bottom-up approaches to study various phenomena in the global medical enzyme technology market.

The report includes an elaborate executive summary, along with a snapshot of the growth pattern of various segments and sub-segments included in the scope of the study. Additionally, the report sheds light on the changing competition dynamics in the global medical enzyme technology market. These indices serve as valuable tools for existing market players as well as for entities interested in participating in the global medical enzyme technology market. The next section of the report highlights the USPs, which include key industry events (mergers, acquisitions, partnerships, collaborations, etc.), technological advancements, major research institutes involved, disease prevalence & incidence rate globally with key countries, and COVID-19 pandemic impact on the industry (value chain and short/mid/long term impact), in the global medical enzyme technology market.

The report delves into the competition landscape of the global medical enzyme technology market. Key players operating in the global medical enzyme technology market have been identified and each one of these has been profiled for its distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players profiled in the global medical enzyme technology market report.

Key Questions Answered in Medical Enzyme Technology Market Report

  • What will be the sales revenue generated by medical enzyme technology across all regions during the forecast period?
  • What are the key trends in the global medical enzyme technology market?
  • What are major drivers, restraints, and opportunities in the global medical enzyme technology market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which application segment will generate the maximum revenue by 2030 and which service type segment will expand at the fastest CAGR during the forecast period?

Medical Enzyme Technology Market – Research Objectives and Research Approach

The comprehensive report on the global medical enzyme technology market begins with an overview of the market, followed by the scope and objectives of the study. Following this, the report provides detailed explanation of the objectives of the study and healthcare compliances laid down by accredited agencies in the purview of research in the global medical enzyme technology market. It is followed by market introduction, market dynamics, and an overview of the global medical enzyme technology market, which includes TMR’s analysis of market drivers, restraints, and trends affecting the market. Furthermore, Y-o-Y growth analysis with elaborate insights has been provided to understand the Y-o-Y growth trends of the global market. The next section of the global medical enzyme technology market report highlights the USPs, which include key industry events (mergers, acquisitions, partnerships, collaborations, etc.), technological advancements, major research institutes involved, disease prevalence & incidence rate globally with key countries, and COVID-19 pandemic impact on industry (value chain and short/mid/long term impact), in the global medical enzyme technology market.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller sections. The entire report comprises an exhaustive collection of graphs and tables that are appropriately interspersed in the entire compilation. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of market shares of key segments in the past and at the end of the forecast period.

Revenue generated by key players in the global medical enzyme technology market has been mapped to ascertain the size of the market in terms of value. The forecast presented here assesses the total revenue generated in the global medical enzyme technology market. In order to provide an accurate forecast, we initiated by sizing up the current medical enzyme technology market with the help of the parent market.

The report analyzes the global medical enzyme technology market in terms of enzyme type, application, and region. Key segments under each criteria have been studied at length and the market share of each of these by the end of 2030 has been provided. These valuable insights would help market stakeholders in making informed business decisions for investments in the global medical enzyme technology market.

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

Medical Enzyme Technology Market – Segmentation

Enzyme Type

  • Digestive Enzymes
    • L-asparginase
    • Lactase
    • Others
  • Thrombolytic Enzymes
    • Streptokinase
    • Urokinase
    • Others
  • Hydrolases
    • Hyaluronidase
    • Lysozyme
    • Others
  • Others

Application

  • Disease Treatment
    • Cancer (Chemotherapy)
    • Metabolic Disorders
    • Others
  • Diagnostic Tools
    • Renal Disease
    • Cancer
    • Others
  • Biomedical Research
  • Others

Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Medical Enzyme Technology Market

4. Market Overview

    4.1. Definition

    4.2. Market Indicators

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global Medical Enzyme Technology Market Value (US$ Mn) Forecast, 2018–2030

    4.5. Global Medical Enzyme Technology Market Outlook

5. Key Insights

    5.1. Key Industry Events (Mergers, Acquisitions, Partnerships, Collaborations, etc.)

    5.2. Technological Advancements

    5.3. Major Research Institutes Involved 

    5.4. Disease Prevalence & Incidence Rate Globally in Key Countries

    5.5. COVID-19 Pandemic Impact on Industry (Value Chain and Short / Mid / Long Term Impact)

6. Global Medical Enzyme Technology Market Analysis and Forecast, by Enzyme Type 

    6.1. Introduction 

    6.2. Global Medical Enzyme Technology Market Value Share Analysis, by Enzyme Type

    6.3. Global Medical Enzyme Technology Market Value Forecast, by Enzyme Type, 2018–2030

        6.3.1. Digestive Enzymes

            6.3.1.1. L-asparginase

            6.3.1.2. Lactase

            6.3.1.3. Others

        6.3.2. Thrombolytic Enzymes

            6.3.2.1. Streptokinase

            6.3.2.2. Urokinase

            6.3.2.3. Others

        6.3.3. Hydrolases

            6.3.3.1. Hyaluronidase

            6.3.3.2. Lysozyme

            6.3.3.3. Others

        6.3.4. Others

    6.4. Global Medical Enzyme Technology Market Attractiveness Analysis, by Enzyme Type 

7. Global Medical Enzyme Technology Market Analysis and Forecast, by Application

    7.1. Introduction 

    7.2. Global Medical Enzyme Technology Market Value Share Analysis, by Application

    7.3. Global Medical Enzyme Technology Market Value Forecast, by Application, 2018–2030

        7.3.1. Disease Treatment

            7.3.1.1. Cancer (Chemotherapy)

            7.3.1.2. Metabolic Diseases

            7.3.1.3. Others

        7.3.2. Diagnostic Tools

            7.3.2.1. Renal Disease

            7.3.2.2. Cancer

            7.3.2.3. Others

        7.3.3. Biomedical Research

        7.3.4. Others

    7.4. Global Medical Enzyme Technology Market Attractiveness Analysis, by Application

8. Global Medical Enzyme Technology Market Analysis and Forecast, by Region 

    8.1. Regional Outlook

    8.2. Introduction

    8.3. Global Medical Enzyme Technology Market Value Forecast, by Region

        8.3.1. North America

        8.3.2. Europe 

        8.3.3. Asia Pacific

        8.3.4. Latin America 

        8.3.5. Middle East & Africa

    8.4.  Global Medical Enzyme Technology Market Attractiveness Analysis, by Region

9. North America Medical Enzyme Technology Market Analysis and Forecast

    9.1.  Key Findings

    9.2.  North America Medical Enzyme Technology Market Value Forecast, by Enzyme Type, 2018–2030

        9.2.1. Digestive Enzymes

            9.2.1.1. L-asparginase

            9.2.1.2. Lactase

            9.2.1.3. Others

        9.2.2. Thrombolytic Enzymes

            9.2.2.1. Streptokinase

            9.2.2.2. Urokinase

            9.2.2.3. Others

        9.2.3. Hydrolases

            9.2.3.1. Hyaluronidase

            9.2.3.2. Lysozyme

            9.2.3.3. Others

        9.2.4. Others

    9.3. North America Medical Enzyme Technology Market Value Forecast, by Application, 2018–2030

        9.3.1. Disease Treatment

            9.3.1.1. Cancer (Chemotherapy)

            9.3.1.2. Metabolic Diseases

            9.3.1.3. Others

        9.3.2. Diagnostic Tools

            9.3.2.1. Renal Disease

            9.3.2.2. Cancer

            9.3.2.3. Others

        9.3.3. Biomedical Research

        9.3.4. Others

    9.4. North America Medical Enzyme Technology Market Value Forecast, by Country, 2018–2030

        9.4.1. U.S.

        9.4.2. Canada

    9.5. North America Medical Enzyme Technology Market Attractiveness Analysis

        9.5.1. By Enzyme Type

        9.5.2. By Application

        9.5.3. By Country

10. Europe Medical Enzyme Technology Market Analysis and Forecast

    10.1.  Key Findings

    10.2.  Europe Medical Enzyme Technology Market Value Forecast, by Enzyme Type, 2018–2030

        10.2.1. Digestive Enzymes

            10.2.1.1. L-asparginase

            10.2.1.2. Lactase

            10.2.1.3. Others

        10.2.2. Thrombolytic Enzymes

            10.2.2.1. Streptokinase

            10.2.2.2. Urokinase

            10.2.2.3. Others

        10.2.3. Hydrolases

            10.2.3.1. Hyaluronidase

            10.2.3.2. Lysozyme

            10.2.3.3. Others

        10.2.4. Others

    10.3. Europe Medical Enzyme Technology Market Value Forecast, by Application, 2018–2030

        10.3.1. Disease Treatment

            10.3.1.1. Cancer (Chemotherapy)

            10.3.1.2. Metabolic Diseases

            10.3.1.3. Others

        10.3.2. Diagnostic Tools

            10.3.2.1. Renal Disease

            10.3.2.2. Cancer

            10.3.2.3. Others

        10.3.3. Biomedical Research

        10.3.4. Others

    10.4. Europe Medical Enzyme Technology Market Value Forecast, by Country/Sub-region, 2018–2030

        10.4.1. U.K.

        10.4.2. Germany

        10.4.3. France

        10.4.4. Italy 

        10.4.5. Spain

        10.4.6. Rest of Europe

    10.5. Europe Medical Enzyme Technology Market Attractiveness Analysis

        10.5.1. By Enzyme Type

        10.5.2. By Application

        10.5.3. By Country/Sub-region

11. Asia Pacific Medical Enzyme Technology Market Analysis and Forecast

    11.1. Key Findings

    11.2. Asia Pacific Medical Enzyme Technology Market Value Forecast, By Enzyme Type, 2018-2030

        11.2.1. Digestive Enzymes

            11.2.1.1. L-asparginase

            11.2.1.2. Lactase

            11.2.1.3. Others

        11.2.2. Thrombolytic Enzymes

            11.2.2.1. Streptokinase

            11.2.2.2. Urokinase

            11.2.2.3. Others

        11.2.3. Hydrolases

            11.2.3.1. Hyaluronidase

            11.2.3.2. Lysozyme

            11.2.3.3. Others

        11.2.4. Others

    11.3. Asia Pacific Medical Enzyme Technology Market Value Forecast, by Application, 2018–2030

        11.3.1. Disease Treatment

            11.3.1.1. Cancer (Chemotherapy)

            11.3.1.2. Metabolic Diseases

            11.3.1.3. Others

        11.3.2. Diagnostic Tools

            11.3.2.1. Renal Disease

            11.3.2.2. Cancer

            11.3.2.3. Others

        11.3.3. Biomedical Research

        11.3.4. Others

    11.4. Asia Pacific Medical Enzyme Technology Market Value Forecast, by Country/Sub-region, 2018–2030

        11.4.1. China

        11.4.2. India

        11.4.3. Japan

        11.4.4. Australia & New Zealand 

        11.4.5. Rest of Asia Pacific 

    11.5. Asia Pacific Medical Enzyme Technology Market Attractiveness Analysis

        11.5.1. By Enzyme Type

        11.5.2. By Application

        11.5.3. By Country/Sub-region

12. Latin America Medical Enzyme Technology Market Analysis and Forecast

    12.1.  Key Findings

    12.2. Latin America Medical Enzyme Technology Market Value Forecast, By Enzyme Type, 2018-2030

        12.2.1. Digestive Enzymes

            12.2.1.1. L-asparginase

            12.2.1.2. Lactase

            12.2.1.3. Others

        12.2.2. Thrombolytic Enzymes

            12.2.2.1. Streptokinase

            12.2.2.2. Urokinase

            12.2.2.3. Others

        12.2.3. Hydrolases

            12.2.3.1. Hyaluronidase

            12.2.3.2. Lysozyme

            12.2.3.3. Others

        12.2.4. Others

    12.3. Latin America Medical Enzyme Technology Market Value Forecast, by Application, 2018–2030

        12.3.1. Disease Treatment

            12.3.1.1. Cancer (Chemotherapy)

            12.3.1.2. Metabolic Diseases

            12.3.1.3. Others

        12.3.2. Diagnostic Tools

            12.3.2.1. Renal Disease

            12.3.2.2. Cancer

            12.3.2.3. Others

        12.3.3. Biomedical Research

        12.3.4. Others

    12.4. Latin America Medical Enzyme Technology Market Value Forecast, by Country/Sub-region, 2018–2030

        12.4.1. Brazil 

        12.4.2. Mexico

        12.4.3. Rest of Latin America

    12.5. Latin America Medical Enzyme Technology Market Attractiveness Analysis

        12.5.1. By Enzyme Type

        12.5.2. By Application

        12.5.3. By Country/Sub-region

13. Middle East & Africa Medical Enzyme Technology Market Analysis and Forecast

    13.1.  Key Findings

    13.2. Middle East & Africa Medical Enzyme Technology Market Value Forecast, By Enzyme Type, 2018-2030

        13.2.1. Digestive Enzymes

            13.2.1.1. L-asparginase

            13.2.1.2. Lactase

            13.2.1.3. Others

        13.2.2. Thrombolytic Enzymes

            13.2.2.1. Streptokinase

            13.2.2.2. Urokinase

            13.2.2.3. Others

        13.2.3. Hydrolases

            13.2.3.1. Hyaluronidase

            13.2.3.2. Lysozyme

            13.2.3.3. Others

        13.2.4. Others

    13.3.  Middle East & Africa Medical Enzyme Technology Market Value Forecast, by Application, 2018–2030

        13.3.1. Disease Treatment

            13.3.1.1. Cancer (Chemotherapy)

            13.3.1.2. Metabolic Diseases

            13.3.1.3. Others

        13.3.2. Diagnostic Tools

            13.3.2.1. Renal Disease

            13.3.2.2. Cancer

            13.3.2.3. Others

        13.3.3. Biomedical Research

        13.3.4. Others

    13.4.  Middle East & Africa Medical Enzyme Technology Market Value Forecast, by Country/Sub-region, 2018–2030

        13.4.1. GCC Countries 

        13.4.2. South Africa 

        13.4.3. Rest of Middle East & Africa

    13.5. Middle East & Africa Medical Enzyme Technology Market Attractiveness Analysis

        13.5.1. By Enzyme Type

        13.5.2. By Application

        13.5.3. By Country/Sub-region

14. Competition Landscape

    14.1.  Market Player - Competition Matrix (by Tier and Size of Companies)

    14.2.  Market Share Analysis, by Company, 2019

    14.3. Company Profiles

        14.3.1. Thermo Fisher Scientific Inc.

            14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.1.2. Financial Overview

            14.3.1.3. Product Portfolio

            14.3.1.4. Strategic Overview

            14.3.1.5. SWOT Analysis

        14.3.2. Merck KGaA

            14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.2.2. Financial Overview

            14.3.2.3. Product Portfolio

            14.3.2.4. Strategic Overview

            14.3.2.5. SWOT Analysis

        14.3.3. Genzyme Corporation (Sanofi)

            14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.3.2. Financial Overview

            14.3.3.3. Product Portfolio

            14.3.3.4. Strategic Overview

            14.3.3.5. SWOT Analysis

        14.3.4. Promega Corporation

            14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.4.2. Financial Overview

            14.3.4.3. Product Portfolio

            14.3.4.4. Strategic Overview

            14.3.4.5. SWOT Analysis

        14.3.5. Asahi Kasei Corporation

            14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.5.2. Financial Overview

            14.3.5.3. Product Portfolio

            14.3.5.4. Strategic Overview

            14.3.5.5. SWOT Analysis

        14.3.6. Takeda Pharmaceutical Company Limited 

            14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.6.2. Financial Overview

            14.3.6.3. Product Portfolio

            14.3.6.4. Strategic Overview

            14.3.6.5. SWOT Analysis

        14.3.7. Cytiva (Danaher)

            14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.7.2. Financial Overview

            14.3.7.3. Product Portfolio

            14.3.7.4. Strategic Overview

            14.3.7.5. SWOT Analysis

        14.3.8. Agilent Technologies, Inc.

            14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.8.2. Financial Overview

            14.3.8.3. Product Portfolio

            14.3.8.4. Strategic Overview

            14.3.8.5. SWOT Analysis

        14.3.9. Sun Pharmaceutical Industries Ltd.

            14.3.9.1.  Company Overview (HQ, Business Segments, Employee Strength)

            14.3.9.2. Financial Overview

            14.3.9.3. Product Portfolio

            14.3.9.4. Strategic Overview

            14.3.9.5. SWOT Analysis

        14.3.10.  Amano Enzyme Inc.

            14.3.10.1.  Company Overview (HQ, Business Segments, Employee Strength)

            14.3.10.2. Financial Overview

            14.3.10.3. Product Portfolio

            14.3.10.4. Strategic Overview

            14.3.10.5. SWOT Analysis

        14.3.11.  Novozymes A/S

            14.3.11.1.  Company Overview (HQ, Business Segments, Employee Strength)

            14.3.11.2. Financial Overview

            14.3.11.3. Product Portfolio

            14.3.11.4. Strategic Overview

            14.3.11.5. SWOT Analysis

List of Tables

Table 01: Global Medical Enzyme Technology Market Value (US$ Mn) Forecast, by Enzyme Type, 2018–2030

Table 02: Global Medical Enzyme Technology Market Value (US$ Mn) Forecast, by Digestive Enzymes, 2018–2030

Table 03: Global Medical Enzyme Technology Market Value (US$ Mn) Forecast, by Thrombolytic Enzymes, 2018–2030

Table 04: Global Medical Enzyme Technology Market Value (US$ Mn) Forecast, by Hydrolases, 2018–2030

Table 05: Global Medical Enzyme Technology Market Value (US$ Mn) Forecast, by Application, 2018–2030

Table 06: Global Medical Enzyme Technology Market Value (US$ Mn) Forecast, by Disease Treatment, 2018–2030

Table 07: Global Medical Enzyme Technology Market Value (US$ Mn) Forecast, by Diagnostic Tools, 2018–2030

Table 08: Global Medical Enzyme Technology Market Value (US$ Mn) Forecast, by Region, 2018–2030

Table 09: North America Medical Enzyme Technology Market Value (US$ Mn) Forecast, by Country, 2018–2030

Table 10: North America Medical Enzyme Technology Market Value (US$ Mn) Forecast, by Enzyme Type, 2018–2030

Table 11: North America Medical Enzyme Technology Market Value (US$ Mn) Forecast, by Digestive Enzymes, 2018–2030

Table 12: North America Medical Enzyme Technology Market Value (US$ Mn) Forecast, by Thrombolytic Enzymes, 2018–2030

Table 13: North America Medical Enzyme Technology Market Value (US$ Mn) Forecast, by Hydrolases, 2018–2030

Table 14: North America Medical Enzyme Technology Market Value (US$ Mn) Forecast, by Application, 2018–2030

Table 15: North America Medical Enzyme Technology Market Value (US$ Mn) Forecast, by Disease Treatment, 2018–2030

Table 16: North America Medical Enzyme Technology Market Value (US$ Mn) Forecast, by Diagnostic Tools, 2018–2030

Table 17: Europe Medical Enzyme Technology Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 18: Europe Medical Enzyme Technology Market Value (US$ Mn) Forecast, by Enzyme Type, 2018–2030

Table 19: Europe Medical Enzyme Technology Market Value (US$ Mn) Forecast, by Digestive Enzymes, 2018–2030

Table 20: Europe Medical Enzyme Technology Market Value (US$ Mn) Forecast, by Thrombolytic Enzymes, 2018–2030

Table 21: Europe Medical Enzyme Technology Market Value (US$ Mn) Forecast, by Hydrolases, 2018–2030

Table 22: Europe Medical Enzyme Technology Market Value (US$ Mn) Forecast, by Application, 2018–2030

Table 23: Europe Medical Enzyme Technology Market Value (US$ Mn) Forecast, by Disease Treatment, 2018–2030

Table 24: Europe Medical Enzyme Technology Market Value (US$ Mn) Forecast, by Diagnostic Tools, 2018–2030

Table 25: Asia Pacific Medical Enzyme Technology Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 26: Asia Pacific Medical Enzyme Technology Market Value (US$ Mn) Forecast, by Enzyme Type, 2018–2030

Table 27: Asia Pacific Medical Enzyme Technology Market Value (US$ Mn) Forecast, by Digestive Enzymes, 2018–2030

Table 28: Asia Pacific Medical Enzyme Technology Market Value (US$ Mn) Forecast, by Thrombolytic Enzymes, 2018–2030

Table 29: Asia Pacific Medical Enzyme Technology Market Value (US$ Mn) Forecast, by Hydrolases, 2018–2030

Table 30: Asia Pacific Medical Enzyme Technology Market Value (US$ Mn) Forecast, by Application, 2018–2030

Table 31: Asia Pacific Medical Enzyme Technology Market Value (US$ Mn) Forecast, by Disease Treatment, 2018–2030

Table 32: Asia Pacific Medical Enzyme Technology Market Value (US$ Mn) Forecast, by Diagnostic Tools, 2018–2030

Table 33: Latin America Medical Enzyme Technology Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 34: Latin America Medical Enzyme Technology Market Value (US$ Mn) Forecast, by Enzyme Type, 2018–2030

Table 35: Latin America Medical Enzyme Technology Market Value (US$ Mn) Forecast, by Digestive Enzymes, 2018–2030

Table 36: Latin America Medical Enzyme Technology Market Value (US$ Mn) Forecast, by Thrombolytic Enzymes, 2018–2030

Table 37: Latin America Medical Enzyme Technology Market Value (US$ Mn) Forecast, by Hydrolases, 2018–2030

Table 38: Latin America Medical Enzyme Technology Market Value (US$ Mn) Forecast, by Application, 2018–2030

Table 39: Latin America Medical Enzyme Technology Market Value (US$ Mn) Forecast, by Disease Treatment, 2018–2030

Table 40: Latin America Medical Enzyme Technology Market Value (US$ Mn) Forecast, by Diagnostic Tools, 2018–2030

Table 41: Middle East & Africa Medical Enzyme Technology Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 42: Middle East & Africa Medical Enzyme Technology Market Value (US$ Mn) Forecast, by Enzyme Type, 2018–2030

Table 43: Middle East & Africa Medical Enzyme Technology Market Value (US$ Mn) Forecast, by Digestive Enzymes, 2018–2030

Table 44: Middle East & Africa Medical Enzyme Technology Market Value (US$ Mn) Forecast, by Thrombolytic Enzymes, 2018–2030

Table 45: Middle East & Africa Medical Enzyme Technology Market Value (US$ Mn) Forecast, by Hydrolases, 2018–2030

Table 46: Middle East & Africa Medical Enzyme Technology Market Value (US$ Mn) Forecast, by Application, 2018–2030

Table 47: Middle East & Africa Medical Enzyme Technology Market Value (US$ Mn) Forecast, by Disease Treatment, 2018–2030

Table 48: Middle East & Africa Medical Enzyme Technology Market Value (US$ Mn) Forecast, by Diagnostic Tools, 2018–2030

List of Figures

Figure 01: Global Medical Enzyme Technology Market

Figure 02: Global Medical Enzyme Technology Market Value (US$ Mn) by Region, 2019 and 2030

Figure 03: Global Medical Enzyme Technology Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2018–2030

Figure 04: Global Medical Enzyme Technology Market Value Share, by Enzyme Type, 2020

Figure 05: Global Medical Enzyme Technology Market Value Share, by Application, 2020

Figure 06: Global Medical Enzyme Technology market Value Share, by Region, 2020

Figure 08: Global Medical Enzyme Technology Market Attractiveness, by Enzyme Type, 2020–2030

Figure 07: Global Medical Enzyme Technology Market Value Share, by Enzyme Type, 2019 and 2030

Figure 09: Global Medical Enzyme Technology Market Value Share, by Digestive Enzymes, 2019 and 2030

Figure 10: Global Medical Enzyme Technology Market Attractiveness, by Digestive Enzymes, 2020–2030

Figure 11: Global Medical Enzyme Technology Market Value Share, by Thrombolytic Enzymes, 2019 and 2030

Figure 12: Global Medical Enzyme Technology Market Attractiveness, by Thrombolytic Enzymes, 2020–2030

Figure 13: Global Medical Enzyme Technology Market Value Share, by Hydrolases, 2019 and 2030

Figure 14: Global Medical Enzyme Technology Market Attractiveness, by Hydrolases, 2020–2030

Figure 15: Global Medical Enzyme Technology Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Digestive Enzymes, 2018–2030

Figure 16: Global Medical Enzyme Technology Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Thrombolytic Enzymes, 2018–2030

Figure 17: Global Medical Enzyme Technology Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Hydrolases, 2018–2030

Figure 18: Global Medical Enzyme Technology Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Others, 2018–2030

Figure 19: Global Medical Enzyme Technology Market Value Share, by Application, 2019 and 2030

Figure 20: Global Medical Enzyme Technology Market Attractiveness, by Application, 2020–2030

Figure 21: Global Medical Enzyme Technology Market Value Share, by Disease Treatment, 2019 and 2030

Figure 22: Global Medical Enzyme Technology Market Attractiveness, by Disease Treatment, 2020–2030

Figure 23: Global Medical Enzyme Technology Market Value Share, by Diagnostic Tools, 2019 and 2030

Figure 24: Global Medical Enzyme Technology Market Attractiveness, by Diagnostic Tools, 2020–2030

Figure 25: Global Medical Enzyme Technology Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Disease Treatment, 2018–2030

Figure 26: Global Medical Enzyme Technology Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Diagnostic Tools, 2018–2030

Figure 27: Global Medical Enzyme Technology Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Biomedical Research, 2018–2030

Figure 28: Global Medical Enzyme Technology Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Others, 2018–2030

Figure 29: Medical Enzyme Technology Market: Regional Outlook

Figure 30: Global Medical Enzyme Technology Market Value (US$ Mn) and Y-o-Y Growth Rate (%) Forecast, 2018–2030

Figure 31: Global Medical Enzyme Technology Market Value Share, by Region, 2019 and 2030

Figure 32: Global Medical Enzyme Technology Market Attractiveness, by Region, 2020–2030

Figure 33: North America Medical Enzyme Technology Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2018–2030

Figure 34: Global Medical Enzyme Technology Market Value Share, by Country, 2019 and 2030

Figure 35: Global Medical Enzyme Technology Market Attractiveness, by Country, 2020–2030

Figure 36: Global Medical Enzyme Technology Market Value Share, by Enzyme Type, 2019 and 2030

Figure 37: Global Medical Enzyme Technology Market Attractiveness, by Enzyme Type, 2020–2030

Figure 38: Global Medical Enzyme Technology Market Value Share, by Application, 2019 and 2030

Figure 39: Global Medical Enzyme Technology Market Attractiveness, by Application, 2020–2030

Figure 40: Europe Medical Enzyme Technology Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2018–2030

Figure 41: Global Medical Enzyme Technology Market Value Share, by Country/Sub-region, 2019 and 2030

Figure 42: Global Medical Enzyme Technology Market Attractiveness, by Country/Sub-region, 2020–2030

Figure 43: Global Medical Enzyme Technology Market Value Share, by Enzyme Type, 2019 and 2030

Figure 44: Global Medical Enzyme Technology Market Attractiveness, by Enzyme Type, 2020–2030

Figure 45: Global Medical Enzyme Technology Market Value Share, by Application, 2019 and 2030

Figure 46: Global Medical Enzyme Technology Market Attractiveness, by Application, 2020–2030

Figure 47: Asia Pacific Medical Enzyme Technology Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2018–2030

Figure 48: Global Medical Enzyme Technology Market Value Share, by Country/Sub-region, 2019 and 2030

Figure 49: Global Medical Enzyme Technology Market Attractiveness, by Country/Sub-region, 2020–2030

Figure 50: Global Medical Enzyme Technology Market Value Share, by Enzyme Type, 2019 and 2030

Figure 51: Global Medical Enzyme Technology Market Attractiveness, by Enzyme Type, 2020–2030

Figure 52: Global Medical Enzyme Technology Market Value Share, by Application, 2019 and 2030

Figure 53: Global Medical Enzyme Technology Market Attractiveness, by Application, 2020–2030

Figure 54: Latin America Medical Enzyme Technology Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2018–2030

Figure 55: Latin America Medical Enzyme Technology Market Value Share, by Country/Sub-region, 2019 and 2030

Figure 56: Latin America Medical Enzyme Technology Market Attractiveness, by Country/Sub-region, 2020–2030

Figure 57: Latin America Medical Enzyme Technology Market Value Share, by Enzyme Type, 2019 and 2030

Figure 58: Latin America Medical Enzyme Technology Market Attractiveness, by Enzyme Type, 2020–2030

Figure 59: Latin America Medical Enzyme Technology Market Value Share, by Application, 2019 and 2030

Figure 60: Latin America Medical Enzyme Technology Market Attractiveness, by Application, 2020–2030

Figure 61: Middle East & Africa Medical Enzyme Technology Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2018–2030

Figure 62: Middle East & Africa Medical Enzyme Technology Market Value Share, by Country/Sub-region, 2019 and 2030

Figure 63: Middle East & Africa Medical Enzyme Technology Market Attractiveness, by Country/Sub-region, 2020–2030

Figure 64: Middle East & Africa Medical Enzyme Technology Market Value Share, by Enzyme Type, 2019 and 2030

Figure 65: Middle East & Africa Medical Enzyme Technology Market Attractiveness, by Enzyme Type, 2020–2030

Figure 66: Middle East & Africa Medical Enzyme Technology Market Value Share, by Application, 2019 and 2030

Figure 67: Middle East & Africa Medical Enzyme Technology Market Attractiveness, by Application, 2020–2030

Figure 68: Global Medical Enzyme Technology Market Analysis, by Top Company Ranking, 2019

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

Request Customization

Medical Enzymes Technology